| Marisol J Skibin, PT | |
|
6624 Fannin St, Suite 2600, Houston, TX 77030-2312 | |
| (713) 790-1818 | |
| (713) 790-7500 |
| Full Name | Marisol J Skibin |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 6624 Fannin St, Houston, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003854639 | NPI | - | NPPES |
| 08T0290 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1026474 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marisol J Skibin, PT 6624 Fannin St, Suite 2600, Houston, TX 77030-2312 Ph: (713) 790-1818 | Marisol J Skibin, PT 6624 Fannin St, Suite 2600, Houston, TX 77030-2312 Ph: (713) 790-1818 |
News Archive
U.S. hospitals are reducing bloodstream infections related to catheters by implementing rigorous safeguards that also save millions of healthcare dollars each year, according to research led by Cedars-Sinai.
CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today the Company has received approval from the United States Food and Drug Administration (FDA) to commence patient screening of a Phase 2b study of PRO 140, a monoclonal CCR5 antibody, for the treatment of patients with Human Immunodeficiency Virus Type 1.
Children in the U.S. are just as likely to die from gunshot wounds if they live in the largest cities or the smallest towns. However, teens living in the most urban counties are more likely to die from gun violence, while children in the most remote areas of the country are more likely to die in gun-related accidents or suicides, according to new research by The Children's Hospital of Philadelphia.
Vertex Pharmaceuticals Incorporated today announced a modification of its Phase 2 clinical trial evaluating 12-week, response-guided regimens of its lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.
The ALS Association is pleased to announce the award of $326,662 in research funds to expand ongoing natural history studies in order to further understand the most common genetic cause of ALS, in preparation for clinical trials in those whose disease is affected by this gene.
› Verified 9 days ago
Mr. Ruben Isidro Bautista, LPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7333 North Freeway #290, Metropolitan Physical Therapy, Houston, TX 77076 Phone: 713-691-7368 Fax: 713-691-0527 | |
Fariborz Nezamabadi, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5868 Westheimer Rd # 211, Houston, TX 77057 Phone: 832-605-4487 | |
Vishal M Patel, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 13428 Bissonnet Street, Houston, TX 77083 Phone: 408-834-0888 | |
Marcille C Baumgartner, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6624 Fannin, Suite 2600, Houston, TX 77030 Phone: 713-790-1818 Fax: 713-790-7500 | |
Medirehab And Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8831 Long Point Rd, Suite 103, Houston, TX 77055 Phone: 713-365-9100 Fax: 713-365-9101 | |
Rachael Lynne Mervine, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1615 Hermann Dr, Unit 1112, Houston, TX 77004 Phone: 413-627-1239 | |
Marc Gardner, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6213 Skyline Dr, #200, Houston, TX 77057 Phone: 713-880-4400 Fax: 713-869-8637 |